KEAP1 and neoplasm: Loss of the aforementioned tumor suppressors, APC, KEAP1, STK11/LKB1, and PTEN, significantly enhanced tumor burden and increased tumor cell proliferation when compared with KPCRISPR (Figure 4D and Supplementary Figure 4E).